Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | AZN | AMGN | GILD | BMY |
| Company | Verona Pharma Plc ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 106.85 | 183.36 | 332.32 | 133.55 | 55.90 |
| High | 106.93 | 187.78 | 338.00 | 135.07 | 56.83 |
| Low | 106.81 | 183.33 | 330.06 | 131.88 | 55.85 |
| Latest | 106.91 | 187.72 | 336.45 | 133.05 | 56.39 |
| Change | +0.12 | +3.18 | +0.16 | -1.89 | -0.06 |
| % Change | +0.11% | +1.72% | +0.05% | -1.40% | -0.11% |
| Volume | 1,871,900 | 1,733,000 | 2,183,700 | 6,666,700 | 7,997,400 |
| 20-Day Average Volume | 1,504,320 | 2,084,500 | 2,690,620 | 6,210,530 | 10,213,665 |
| Previous Close | 106.79 | 184.54 | 336.29 | 134.94 | 56.45 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 188.96 | 339.02 | 133.00 | 57.92 |
| 20-Day Raw Stochastic | 98.26% | 30.51% | 43.79% | 42.85% | 18.33% |
| 20-Day Relative Strength | 70.52 | 46.57 | 45.42 | 45.77 | 44.08 |
| Weighted Alpha | +201.62 | +30.14 | +18.93 | +24.32 | +20.21 |
| Today's Opinion | 100% Buy | 8% Buy | 24% Sell | 24% Buy | 16% Buy |
| Previous Opinion | 100% Buy | 8% Sell | 8% Sell | 24% Buy | 24% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Buy | 56% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | +1.51% since 05/06/26 | +1.61% since 05/06/26 | -2.38% since 05/06/26 | -0.35% since 05/06/26 |
| Low | 106.61 on 09/30/25 | 181.03 on 05/07/26 | 327.22 on 05/07/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 106.93 on 10/06/25 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.02 on 05/12/26 |
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | -7.18% since 04/13/26 | -3.82% since 04/13/26 | -4.30% since 04/13/26 | -2.88% since 04/13/26 |
| Low | 105.78 on 09/19/25 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 106.93 on 10/06/25 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | -8.67% since 02/13/26 | -8.87% since 02/13/26 | -14.15% since 02/13/26 | -7.16% since 02/13/26 |
| Low | 86.63 on 07/08/25 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 106.93 on 10/06/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +5.92% since 11/13/25 | +0.13% since 11/13/25 | +6.27% since 11/13/25 | +15.96% since 11/13/25 |
| Low | 47.20 on 04/07/25 | 176.56 on 11/14/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 106.93 on 10/06/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 286,204,544 | 181,490,688 | 167,537,456 | 115,274,912 |
| Shares Outstanding, K | 81,830 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 42,280,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -173,420,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 103,140,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 11,920,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.05 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 11/03/25 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.64 | 14.91 | 15.95 | 9.39 |